Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2058-7716
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity ; volume:5 ; number:1 ; day:12 ; month:6 ; year:2019 ; pages:1-11 ; date:12.2019
Cell death discovery ; 5, Heft 1 (12.6.2019), 1-11, 12.2019
- Creator
-
McSweeney, K. Melodi
Bozza, William P.
Alterovitz, Wei-Lun
Zhang, Baolin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41420-019-0182-6
- URN
-
urn:nbn:de:101:1-2019090609070880959764
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McSweeney, K. Melodi
- Bozza, William P.
- Alterovitz, Wei-Lun
- Zhang, Baolin
- SpringerLink (Online service)
Other Objects (12)
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
GAS-STING signaling plays an essential pathogenetic role in Doxorubicin-Induced Cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
GAS-STING signaling plays an essential pathogenetic role in Doxorubicin-Induced Cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis